The factsheet has been successfully sent.
Please check your inbox.
Please fill in the form to receive the factsheet directly into your inbox

You have items in your inquiry list.
Inquire now?

15 November 2021 [Press release]

GenoScreen™ SARS-CoV-2 RT-qPCR Assay again 100% Proficient in latest QCMD EQA Programme (October 2021)

The QCMD (Quality Control for Molecular Diagnostic) is an external quality assurance programme that helps to monitor and improve quality within clinical laboratories. Their SARS-CoV-2 EQA programme assesses the sensitivity of assays routinely used for molecular detection of SARS-CoV-2 at clinically appropriate levels, near the limit of detection as well as the specificity of assays in the presence of other human coronaviruses.

In the latest October 2021 programme, laboratory using DiagCor’s GenoScreenTM SARS-CoV-2 qRT-PCR Assay, together with DiagPuroTM Nucleic Acid Extraction System and Genesis 96Q Real-time PCR System) has participated and attained fully proficient (100% proficient) status. SARS-CoV-2 variants (B.1, B1.1.7 & B1.351) were being successfully detected. DiagCor Life Science prioritizes high product quality and actively supports SARS-CoV-2 testing services in laboratories worldwide, thus contributing to fight against COVID-19.

Find the full details on the above product pages, or get in touch to learn more!

About DiagCor

Headquartered in Hong Kong with ISO 13485 accredited Quality Management System, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, DiagCor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.

Press Contact

DiagCor Life Science

[email protected]